micro News and Research

RSS

Sensors, a smart dose of medicine for cancer treatment

New sensor systems being developed will help treat cancer and improve the accuracy and reliability of existing radiation treatments. They should help improve patient care and outcomes. The results will go straight to commercialisation when finalised next year.

7 Nov 2005

Mechanisms of evolution may be associated with disease

By comparing the human genome with that of the chimpanzee, man's closest living relative, researchers have discovered that chunks of similar DNA that have been flipped in orientation and reinserted into chromosomes are hundreds of times more common in primates than previously thought.

26 Oct 2005

Nanobombs to eradicate cancer

University of Delaware researchers are opening a new front in the war on cancer, bringing to bear new nanotechnologies for cancer detection and treatment and introducing a unique nanobomb that can literally blow up breast cancer tumors.

13 Oct 2005

Promising new treatment options for prostate cancer

Prostate cancer is the second leading cause of death among American men. It is estimated that one in six males will develop the disease during his lifetime. However, promising new treatment options have been developed to help combat this threatening disease.

9 Oct 2005

Australia's leading medical research institutes recognise that the Australian Synchrotron

The President of the Australian Association of Medical Research Institutes (AAMRI), Professor Suzanne Cory, has announced that AAMRI would become a partner in the Australian Synchrotron.

3 Oct 2005

Microchip system aims to reduce the number of animals used in the development of new drugs

Reducing the number of animals used in the development of new drugs is a priority for the pharmaceutical industry

26 Sep 2005

Concerns over the privacy of patients could be hampering efforts to spot disease clusters

...and monitor the health effects of environmental pollution, according to researchers in the latest edition of the Journal of Biomedical Informatics.

12 Sep 2005

State-of-the-art portable biosensing device based on micro and nanotechnologies

A state-of-the-art portable biosensing device based on micro- and nanotechnologies will empower doctors to rapidly and accurately forewarn patients of their genetic risk of developing diseases such as cancer.

23 Aug 2005

ev3 announces FDA approval of treatment for brain vascular disorder

ev3 today announced that its majority-owned subsidiary Micro Therapeutics has received pre-market application (PMA) approval from the U.S. Food and Drug Administration (FDA) to commercialize its Onyx Liquid Embolic System (Onyx) for the treatment of arterio-venous malformations (AVMs), a vascular disorder in the brain.

21 Jul 2005

Researchers modify software to predict gene transcription

A modification to an "ace" gene prediction program by computer scientists at Washington University in St. Louis now enables scientists to predict the very beginnings of gene transcription start sites and where the first splice occurs thereby defining the first exon of the gene.

13 Jul 2005

Holographic movies show promise for medical applications

In a small research laboratory at UT Southwestern Medical Center, a grainy, red movie of circling fighter jets emerges from a table-top black box, while nearby, a video of a rotating human heart hangs suspended in a tank of gooey gel.

14 Jun 2005

New study shows tiny RNAs intimately associated with cancer

In discoveries that may open a new chapter in understanding and diagnosing cancer, Howard Hughes Medical Institute (HHMI) investigators and their colleagues have established that tiny microRNAs provide a novel genetic route to the initiation of some forms of cancer.

9 Jun 2005

Novel topical treatment of psoriasis

Cytochroma Inc. today announced results from a Phase Ia clinical study for CTA018, a novel vitamin D analog developed for the treatment of psoriasis.

2 Jun 2005

Sensor warns of gastrointestinal problems

Dutch researcher Sebastiaan Herber has developed a sensor which can detect poor blood circulation in the stomach. A high level of carbon dioxide in the stomach is a characteristic of this so-called gastrointestinal ischaemia. By measuring this concentration the sensor can indicate how good or bad the circulation in the stomach wall is.

17 May 2005

Robotic surgery dramatically reduces physical trauma for head & neck cancer patients

For patients with cancer of the mouth and throat, surgery is a frequent course of treatment, often leading to speech and swallowing dysfunction and external scarring.

15 May 2005

Faulty folding of protein in the environment may cause disease

Serious diseases like Alzheimer's and type-2 diabetes have been shown to be related to unhealthy protein chains that occur when proteins fold incorrectly. In an article in the scientific journal Proceedings of the National Academy of Science, PNAS, a research team directed from Uppsala University shows that similar protein chains in our environment may hasten the process.

4 May 2005

New method for obtaining sequence information from thousands of genomes simultaneously

One of the world’s leading scientists, Nobel Prize winner, Dr Sydney Brenner, has devised a new method for obtaining sequence information from thousands of genomes simultaneously. Current technologies can only analyse one genome at a time.

20 Apr 2005

Researchers insert engineered human stem cells into the spinal cords of ALS-afflicted rats

Unveiling a delivery method that may one day help surgeons treat the deadly neurodegenerative disease amyotrophic lateral sclerosis (ALS), researchers at the University of Wisconsin-Madison have inserted engineered human stem cells into the spinal cords of ALS-afflicted rats.

19 Apr 2005

Micro-organisms in clouds could play a crucial role in the spread of disease

The radical theories about nanobacteria – micro-organisms considerably smaller than ordinary bacteria - in clouds are published in two recent articles in the Journal of Proteome Research by Dr Andrei P. Sommer of the University of Ulm, Germany, and Professor Chandra Wickramasinghe of Cardiff University, UK.

6 Apr 2005

Statins, other cholesterol-depleting agents, may disrupt hypertension from developing

Cholesterol-lowering agents, such as the widely-prescribed statin drugs, and cholesterol-blocking agents may prove to be “novel therapeutic agents to modify cellular calcium that contributes to the development of pulmonary hypertension,” according Hemal H. Patel who lead a multidisciplinary team of researchers at the University of California, San Diego (UCSD).

3 Apr 2005